Cargando…
MON-167 Hypoglycemia Prevention: A Quality Improvement Project to Reduce Inpatient Hypoglycemia Rate Following Treatment of Hyperkalemia
Background: The use of fixed doses of intravenous insulin and dextrose for hyperkalemia treatment is well-established. Iatrogenic hypoglycemia as a result of treatment although common, can have negative consequences. Literature reveals various practices to minimize hypoglycemia risk. Aim: Our aim wa...
Autores principales: | Khan, Nushin, Yoon, Samuel, Peragallo-Dittko, Virginia, Islam, Shahidul, Sahay, Priya, Cohen, Melissa, Wendel, Jane, Halstrom, Amanda, Groysman, Anna, Rubinova, Rakhil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550832/ http://dx.doi.org/10.1210/js.2019-MON-167 |
Ejemplares similares
-
MON-168 Hypoglycemia in Diabetics 65 Years and Older in Africans and Ademolus Classification of Hypoglycemia
por: Ademolu, Adegbenga
Publicado: (2019) -
MON-146 Prolonged Hypoglycemia in the Setting of Synthetic Cathinone Abuse
por: Ramirez Berlioz, Ana, et al.
Publicado: (2019) -
SAT138 “Zero”Ing On Hypoglycemia Caused By Hyperkalemia Treatments In The Inpatient Setting
por: Kim, Steve, et al.
Publicado: (2023) -
Inpatient Hypoglycemia in Patients With Chronic Kidney Disease
por: Do, Justin, et al.
Publicado: (2021) -
MON-134 Use of CGMS for Evaluating Hypoglycemia in Non-Diabetic Patients
por: Shrestha, Isha, et al.
Publicado: (2019)